Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Edap Tms SA EDAP

Healthcare Medical Devices
Edap Tms SA is a France-based company that develops, manufactures, promotes and distributes minimally invasive medical devices for urology based upon ultrasound technology. The Company's activity is organized in two divisions: HIFU (High Intensity Focused Ultrasound) and ESWL (Extracorporeal ShockWave Lithotripsy) that invests in research and development, partnering with INSERM French public... see more

Recent & Breaking News (NDAQ:EDAP)

EDAP TMS SA Due Diligence Report: Upward Trend and Upcoming Catalysts; Investors Anxious

Accesswire November 10, 2015

EDAP Announces Focal One(R) HIFU Sale to Clinica Santa Maria de Santiago de Chile

GlobeNewswire November 10, 2015

EDAP Receives FDA Approval for Ablatherm HIFU

GlobeNewswire November 9, 2015

EDAP Reports on Recent, Active Urology Congress and Clinical Activity

GlobeNewswire November 3, 2015

EDAP Direct De Novo for Ablatherm HIFU Replaced by 510(k)

GlobeNewswire October 15, 2015

EDAP Reports Growing Momentum in Europe for HIFU Treatment of Prostate Cancer

GlobeNewswire September 24, 2015

EDAP TMS to Present at Rodman and Renshaw Global Investment Conference

GlobeNewswire September 2, 2015

EDAP Reports Strong Year-over-Year Revenue Growth in Second Quarter 2015

GlobeNewswire August 26, 2015

EDAP Provides Formal Response to FDA Addressing All Concerns Raised in July 2015 Ablatherm HIFU Letter

GlobeNewswire August 25, 2015

EDAP to Hold Second Quarter 2015 Conference Call on August 27, 2015

GlobeNewswire August 19, 2015

EDAP Receives Feedback From FDA on Direct De Novo 510(k) Petition for Ablatherm HIFU

GlobeNewswire July 21, 2015

EDAP Names Francois Dietsch Chief Financial Officer

GlobeNewswire July 14, 2015

EDAP's Focal One(R) HIFU Device Adopted by Two University Hospitals in Switzerland

GlobeNewswire July 7, 2015

EDAP Announces Senior Management Transition

GlobeNewswire July 2, 2015

EDAP Announces Focal One(R) HIFU Installation at Germany's Martini-Klinik

GlobeNewswire June 9, 2015

EDAP Reports First Quarter 2015 Results

GlobeNewswire May 12, 2015

EDAP to Report First Quarter 2015 Results on May 13, 2015

GlobeNewswire May 6, 2015

EDAP Reports Fourth Quarter and Full Year 2014 Results

GlobeNewswire April 1, 2015

EDAP Announces Sale of First Focal One(R) HIFU Device in North America

GlobeNewswire March 31, 2015

EDAP to Participate in Major, Multi-Partner Liver Cancer Development Project

GlobeNewswire March 26, 2015